Sensory Characteristics and Psychosocial Factors Related With Non-specific Neck Musculoskeletal Pain Chronification (CNSNP)
22 janvier 2021 mis à jour par: Pablo Herrero Gallego, Universidad San Jorge
Chronic pain is commonly defined as any pain which lasts more than 12 weeks.
Chronic non-specific neck pain (CNSNP) has no specific underlying disease causing the pain.
There are neurophysiological factors that may modulate pain response and perception in the central nervous system, producing sensory changes such as the presence of temporal summation (TS) and pressure, cold or heat hyperalgesia.
TS describes the progressive increase in reported pain intensity as a function of repeated noxious stimulation (e.g.
thermal, electrical or mechanical).
TS and hyperalgesia are measured through quantitative sensory tests (QST) where pain pressure thresholds (PPT) are measured with an algometer.
The current evidence show that PPTs are significantly lower compared to healthy subjects and the association between PPTs, pain intensity and disability are inconsistent.
Further, there are psychosocial factors (catastrophizing, kinesiophobia, stress…) that may influence the pain experience.
This psychosocial factors associated with chronic pain are not systematically collected in the QST literature complicating the interpretation of data.
The objectives of this study are 1) to determine disability, sensory (TS and PPTs) and psychosocial changes (kinesiophobia, catastrophizing, sleep quality, life quality, stress and anxiety) in the natural evolution or in the result of physiotherapy treatment in CNSNP individuals, 2) to study the correlations between disability, psychosocial and sensory factors and 3) to observe if there is a homogeneity between the subjects.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Type d'étude
Observationnel
Inscription (Réel)
68
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
-
Zaragoza, Espagne, 50009
- Hospital General de la Defensa
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
18 ans à 65 ans (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Oui
Sexes éligibles pour l'étude
Tout
Méthode d'échantillonnage
Échantillon non probabiliste
Population étudiée
The study was divided into 2 groups: individuals with Chronic Non-Specific Neck Pain and healthy controls.
La description
Inclusion criteria for individuals with CNSNP were:
- age between 18 and 65 years;
- capable to understand, write, and speak in Spanish;
- having suffered neck pain during the last 12 weeks at least;
- pain localized in the neck region with or without pain radiation;
- Negative Spurling test;
- Negative Self-Administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS);
- Negative Upper Limb Tension Test for the median nerve;
- PainDetect test with non-neuropathic pain result. .
Exclusion Criteria:
- Presence of red flag as reported in the medical history (i.e. tumor, fracture, metabolic diseases, rheumatoid arthritis, osteoporosis);
- Neck pain with cervical radiculopathy;
- fibromyalgia syndrome,
- previous neck surgery;
- currently undergoing any type of pain treatment or having received physical therapy in the previous 3 months.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Chronic Non-Specific Neck Pain
Patients with chronic non-specific neck pain.
No interventions
|
Observational study
|
|
Control/Healthy Group
Volunteers without pain.
No interventions.
|
Observational study
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Neck Disability Index Change
Délai: T0 (baseline); T1 (1 month); T2 (6 months).
|
It is a 10-item questionnaire that measures a patient's self-reported neck pain related disability.
Questions include activities of daily living, such as: personal care, lifting, reading, work, driving, sleeping, recreational activities, pain intensity, concentration and headache.
The 10 item scores are then summed to yield a global NDI score, which has a range of 0-50 where higher values reflect greater neck disability. 1 and 6-month results were subtracted from baseline.
As such, positive change scores for neck disability indicate improvement
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Quick-DASH change
Délai: T0 (baseline); T1 (1 month); T2 (6 months).
|
The purpose of the QuickDASH is to use 11 items to measure physical function and symptoms in people with any or multiple musculoskeletal disorders of the upper limb.
The QuickDASH is a widely used reference of self reported disability.
The 11 item scores are then summed to yield a global QuickDASH score, which has a range of 11-100 where higher values reflect greater shoulder/arm disability. 1 and 6-month results were subtracted from baseline.
As such, positive change scores for shoulder/arm disability indicate improvement
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Pressure Pain Threshold change
Délai: T0 (baseline); T1 (1 month); T2 (6 months).
|
Pressure pain threshold (PPT) is defined as the minimum force applied which induces pain.
This measure has proven to be commonly useful in evaluating tenderness symptom.
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Temporal Summation change
Délai: T0 (baseline); T1 (1 month); T2 (6 months).
|
Temporal summation is a clinical measure of central sensitization in which a high frequency of action potentials in the presynaptic neuron elicits postsynaptic potentials that overlap and summate with each other.
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Area of pain assessed by bodycharts change
Délai: T0 (baseline); T1 (1 month); T2 (6 months).
|
Participants have to draw on a tablet-based digital body chart (NavigatePain©, Aalborg University, Aalborg, Denmark) the body region in which they felt pain more frequently during the previous month.
The use of pain drawings has been found to be reliable in chronic low back, neck, shoulder, and arm pain.
Digital pain drawings have also been shown reliable, valid and comparable to paper drawings and useful in clinical population.
The size of the pain area was extracted and expressed in pixels.
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Pain Intensity change- Visual Analogic Scale
Délai: T0 (baseline); T1 (1 month); T2 (6 months).
|
Self-perceived neck pain will record using a Visual Analogue Scale (VAS).
Participants have to mark on a 10-cm line their average current neck pain between 0 ("no pain") and 10 ("worst possible pain").
The VAS is a reliable and valid measurement of pain
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Pain Duration change
Délai: T0 (baseline); T1 (1 month); T2 (6 months).
|
Duration of pain in months
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Catastrophism change. Pain Catastrophizing Scale
Délai: T0 (baseline); T1 (1 month); T2 (6 months).
|
People are asked to indicate the degree to which they have the above thoughts and feelings when they are experiencing pain using the 0 (not at all) to 4 (all the time) scale.
A total score is yielded (ranging from 0-52), along with three subscale scores assessing rumination, magnification and helplessness.
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Kinesiophobia change. Tampa Scale for Kinesiophobia
Délai: T0 (baseline); T1 (1 month); T2 (6 months).
|
Tampa Scale for Kinesiophobia (TSK) The TSK is a 17-item self-report measure of fear of movement and (re)injury.
Four of the items are negatively worded and reversed scored (4, 8, 12, and 16).
Ratings are summed to yield a total score where higher values reflect greater fear of (re)injury.
The 17 item scores are then summed to yield a global TSK score, which has a range of 11-44.
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Quality of Life change. The 5-level EQ-5D version (EQ-5D-5L)
Délai: T0 (baseline); T1 (1 month); T2 (6 months).
|
The EQ-5D is a frequently used generic quality of life questionnaire, designed by the EuroQoL.
The EQ-5D-5L is an instrument widely used to measure and evaluate general health status.
The EQ-5D-5L descriptive system describes general health in terms of five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
Each dimension has five levels, indicating no problems, slight problems, moderate problems, severe problems, and extreme problems resulting in a total of 3,125 unique health states.
Besides, the EQ-5D-5L also includes a visual analogue scale (EQ-VAS), which recorded the patient's self-rated health on a 20 cm vertical, visual analogue scale with endpoints (0; 100) labeled 'the best health you can imagine' and 'the worst health you can imagine'
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Stress change. Perceived Stress Scale
Délai: T0 (baseline); T1 (1 month); T2 (6 months).
|
he Perceived Stress Scale (PSS) inquire about feelings and thoughts that tap the degree to which respondents find their current life situation unpredictable, uncontrollable and stressful.
Respondents indicate how often in the past month they have felt or thought a certain way on a 5-point Likert scale (0 = never, 1 = almost never, 2 = sometimes, 3 = fairly often, 4 = very often).
The higher the score the higher the perceived stress is.
The 14 item scores are then summed to yield a global PSS score, which has a range of 0-56
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Quality of Sleep change . Pittsburgh Questionnaire
Délai: T0 (baseline); T1 (1 month); T2 (6 months).
|
PSQI consists of 19 self-rated questions.
The 19 self-rated questions asses a wide variety of factors relating to sleep quality, including estimates of sleep duration and latency and of the frequency and severity of specific sleep-related problems.
Theses 19 items are grouped into seven component scores, each weighted equally on a 0-3 scale.
The seven component scores are then summed to yield a global PSQI score, which has a range of 0-21; higher scores indicate worse sleep quality.
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Anxiety-Depression change. DASS 21.
Délai: T0 (baseline); T1 (1 month); T2 (6 months).
|
The DASS is a self-report measure, designed to assess the unique and unrelated aspects of anxiety and depression, as well as a third construct (termed stress) that assesses the features common to anxiety and depression.
The DASS-21 is comprised of three scales, Depression, Anxiety, and Stress, each of which consists of 7 items.
The 21 item scores are then summed to yield a global DASS-21 score, which has a range of 0-63
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Collaborateurs
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
15 avril 2020
Achèvement primaire (Réel)
15 décembre 2020
Achèvement de l'étude (Réel)
22 janvier 2021
Dates d'inscription aux études
Première soumission
25 mars 2020
Première soumission répondant aux critères de contrôle qualité
30 mars 2020
Première publication (Réel)
1 avril 2020
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
25 janvier 2021
Dernière mise à jour soumise répondant aux critères de contrôle qualité
22 janvier 2021
Dernière vérification
1 janvier 2021
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- CNSNP-USJ
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Description du régime IPD
Data will be provided based on request to authors by email to gortego@usj.es
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .